{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:33:23Z","timestamp":1792024403595,"version":"4.4.0"},"reference-count":30,"publisher":"IMR Press","issue":"5","license":[{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Cardiovasc. Med."],"abstract":"<jats:p>Background: Inflammation is essential in cardiovascular disease (CVD) development and progression. A novel inflammatory parameter, the systemic inflammation response index (SIRI), has been proven to predict cancer prognosis strongly. Little is known about the relationship between SIRI and outcomes in patients with ST-segment elevation myocardial infarction (STEMI). Methods: 1312 STEMI patients who underwent percutaneous coronary intervention (PCI) in Beijing Anzhen hospital from January 2019 to December 2021 were analyzed. SIRI was calculated as neutrophils \u00d7 monocytes\/lymphocytes. Our primary outcome was a 30-day major adverse event (MACE), including all-cause mortality, non-fatal myocardial infarction (MI), stroke, incident heart failure (HF), cardiogenic shock, and cardiac arrest. Results: Patients were stratified into four groups according to quartiles of SIRI: SIRI &lt;1.58 (n = 328), 1.58 \u2264 SIRI &lt; 3.28 (n = 328), 3.28 \u2264 SIRI &lt; 7.80 (n = 328), SIRI \u22657.80 (n = 328). Higher SIRI was associated with a higher incidence of the 30-day MACE. The rates of 30-day MACE were 6.1%, 8.8%, 12.8%, and 17.1% (p &lt; 0.001) for the lowest SIRI quartile to the highest quartile, respectively. This association was consistent in the outcome of HF but no other components. Higher SIRI indicated higher 30-day MACE incidence in most participants except in those with very high inflammatory indicators. Subgroup analysis showed this correlation was consistent in various subgroups (p for interaction &gt;0.05). Conclusions: In patients with STEMI, higher SIRI indicated a higher incidence of 30-day MACE, except for those with very high inflammatory indicators. In most STEMI patients, SIRI might be a trustworthy indicator of short-term prognosis.<\/jats:p>","DOI":"10.31083\/j.rcm2405153","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:50:37Z","timestamp":1684716637000},"source":"Crossref","is-referenced-by-count":17,"title":["The Impact of Systemic Inflammation Response Index on the Prognosis of Patients with ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention"],"prefix":"10.31083","volume":"24","author":[{"given":"Chao","family":"Qu","sequence":"first","affiliation":[{"name":"Center for Coronary Artery Disease, Division of Cardiology, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"first","affiliation":[{"name":"Center for Coronary Artery Disease, Division of Cardiology, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Gao","sequence":"first","affiliation":[{"name":"Center for Coronary Artery Disease, Division of Cardiology, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2023,5,19]]},"reference":[{"key":"ref1","unstructured":"World Health Organization. Cardiovascular diseases (CVDs). 2021. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds) (Accessed: 11 June 2021)."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Dudas K, Lappas G, Stewart S, Rosengren A. Trends in out-of-hospital deaths due to coronary heart disease in Sweden (1991 to 2006). Circulation. 2011; 123: 46\u201352.","DOI":"10.1161\/CIRCULATIONAHA.110.964999"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Alabas OA, Jernberg T, Pujades-Rodriguez M, Rutherford MJ, West RM, Hall M, et al. Statistics on mortality following acute myocardial infarction in 842 897 Europeans. Cardiovascular Research. 2020; 116: 149\u2013157.","DOI":"10.1093\/cvr\/cvz197"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Angkananard T, Anothaisintawee T, McEvoy M, Attia J, Thakkinstian A. Neutrophil Lymphocyte Ratio and Cardiovascular Disease Risk: A Systematic Review and Meta-Analysis. BioMed Research International. 2018; 2018: 2703518.","DOI":"10.1155\/2018\/2703518"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Gaul DS, Stein S, Matter CM. Neutrophils in cardiovascular disease. European Heart Journal. 2017; 38: 1702\u20131704.","DOI":"10.1093\/eurheartj\/ehx244"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Bhat T, Teli S, Rijal J, Bhat H, Raza M, Khoueiry G, et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Review of Cardiovascular Therapy. 2013; 11: 55\u201359.","DOI":"10.1586\/erc.12.159"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Kim S, Eliot M, Koestler DC, Wu WC, Kelsey KT. Association of Neutrophil-to-Lymphocyte Ratio With Mortality and Cardiovascular Disease in the Jackson Heart Study and Modification by the Duffy Antigen Variant. JAMA Cardiology. 2018; 3: 455\u2013462.","DOI":"10.1001\/jamacardio.2018.1042"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Ye Z, Hu T, Wang J, Xiao R, Liao X, Liu M, et al. Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: A systematic review and meta-analysis. Frontiers in Cardiovascular Medicine. 2022; 9: 933913.","DOI":"10.3389\/fcvm.2022.933913"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Qi Q, Zhuang L, Shen Y, Geng Y, Yu S, Chen H, et al. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy. Cancer. 2016; 122: 2158\u20132167.","DOI":"10.1002\/cncr.30057"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Xu L, Yu S, Zhuang L, Wang P, Shen Y, Lin J, et al. Systemic inflammation response index (SIRI) predicts prognosis in hepatocellular carcinoma patients. Oncotarget. 2017; 8: 34954\u201334960.","DOI":"10.18632\/oncotarget.16865"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Chao B, Ju X, Zhang L, Xu X, Zhao Y. A Novel Prognostic Marker Systemic Inflammation Response Index (SIRI) for Operable Cervical Cancer Patients. Frontiers in Oncology. 2020; 10: 766.","DOI":"10.3389\/fonc.2020.00766"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal. 2018; 39: 119\u2013177.","DOI":"10.1093\/eurheartj\/ehx393"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Sk\u00e5l\u00e9n K, Gustafsson M, Rydberg EK, Hult\u00e9n LM, Wiklund O, Innerarity TL, et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature. 2002; 417: 750\u2013754.","DOI":"10.1038\/nature00804"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"B\u00e4ck M, Yurdagul A, Jr, Tabas I, \u00d6\u00f6rni K, Kovanen PT. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nature Reviews Cardiology. 2019; 16: 389\u2013406.","DOI":"10.1038\/s41569-019-0169-2"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Han K, Shi D, Yang L, Wang Z, Li Y, Gao F, et al. Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Annals of Medicine. 2022; 54: 1667\u20131677.","DOI":"10.1080\/07853890.2022.2083671"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Buono C, Binder CJ, Stavrakis G, Witztum JL, Glimcher LH, Lichtman AH. T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses. Proceedings of the National Academy of Sciences of the United States of America. 2005; 102: 1596\u20131601.","DOI":"10.1073\/pnas.0409015102"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Dragu R, Huri S, Zukermann R, Suleiman M, Mutlak D, Agmon Y, et al. Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction. Atherosclerosis. 2008; 196: 405\u2013412.","DOI":"10.1016\/j.atherosclerosis.2006.11.022"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Huang JB, Chen YS, Ji HY, Xie WM, Jiang J, Ran LS, et al. Neutrophil to high-density lipoprotein ratio has a superior prognostic value in elderly patients with acute myocardial infarction: a comparison study. Lipids in Health and Disease. 2020; 19: 59.","DOI":"10.1186\/s12944-020-01238-2"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Kaya MG, Akpek M, Lam YY, Yarlioglues M, Celik T, Gunebakmaz O, et al. Prognostic value of neutrophil\/lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: a prospective, multicenter study. International Journal of Cardiology. 2013; 168: 1154\u20131159.","DOI":"10.1016\/j.ijcard.2012.11.074"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Geng Y, Zhu D, Wu C, Wu J, Wang Q, Li R, et al. A novel systemic inflammation response index (SIRI) for predicting postoperative survival of patients with esophageal squamous cell carcinoma. International Immunopharmacology. 2018; 65: 503\u2013510.","DOI":"10.1016\/j.intimp.2018.10.002"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Jin Z, Wu Q, Chen S, Gao J, Li X, Zhang X, et al. The Associations of Two Novel Inflammation Indexes, SII and SIRI with the Risks for Cardiovascular Diseases and All-Cause Mortality: A Ten-Year Follow-Up Study in 85,154 Individuals. Journal of Inflammation Research. 2021; 14: 131\u2013140.","DOI":"10.2147\/JIR.S283835"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Zhang Y, Xing Z, Zhou K, Jiang S. The Predictive Role of Systemic Inflammation Response Index (SIRI) in the Prognosis of Stroke Patients. Clinical Interventions in Aging. 2021; 16: 1997\u20132007.","DOI":"10.2147\/CIA.S339221"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Dong L, Mintz GS, Witzenbichler B, Metzger DC, Rinaldi MJ, Duffy PL, et al. Comparison of plaque characteristics in narrowings with ST-elevation myocardial infarction (STEMI), non-STEMI\/unstable angina pectoris and stable coronary artery disease (from the ADAPT-DES IVUS Substudy). The American Journal of Cardiology. 2015; 115: 860\u2013866.","DOI":"10.1016\/j.amjcard.2015.01.008"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Di Stefano R, Di Bello V, Barsotti MC, Grigoratos C, Armani C, Dell\u2019Omodarme M, et al. Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models. Biomedicine & Pharmacotherapy. 2009; 63: 773\u2013780.","DOI":"10.1016\/j.biopha.2009.06.004"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Dziedzic EA, G\u0105sior JS, Tuzimek A, Paleczny J, Junka A, D\u0105browski M, et al. Investigation of the associations of novel inflammatory biomarkers-systemic inflammatory index (SII) and systemic inflammatory response index (SIRI)-with the severity of coronary artery disease and acute coronary syndrome occurrence. International Journal of Molecular Sciences. 2022; 23: 9553.","DOI":"10.3390\/ijms23179553"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Maekawa Y, Anzai T, Yoshikawa T, Asakura Y, Takahashi T, Ishikawa S, et al. Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction: a possible role for left ventricular remodeling. Journal of the American College of Cardiology. 2002; 39: 241\u2013246.","DOI":"10.1016\/S0735-1097(01)01721-1"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Dick SA, Epelman S. Chronic Heart Failure and Inflammation: What Do We Really Know? Circulation Research. 2016; 119: 159\u2013176.","DOI":"10.1161\/CIRCRESAHA.116.308030"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Liu Z, Xv Y, Liu X, Zhou X. Associations of systemic inflammatory markers with the risks of chronic heart failure: A case-control study. Clinics. 2022; 77: 100056.","DOI":"10.1016\/j.clinsp.2022.100056"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Vanhaverbeke M, Veltman D, Pattyn N, De Crem N, Gillijns H, Cornelissen V, et al. C-reactive protein during and after myocardial infarction in relation to cardiac injury and left ventricular function at follow-up. Clinical Cardiology. 2018; 41: 1201\u20131206.","DOI":"10.1002\/clc.23017"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Lucci C, Cosentino N, Genovese S, Campodonico J, Milazzo V, De Metrio M, et al. Prognostic impact of admission high-sensitivity C-reactive protein in acute myocardial infarction patients with and without diabetes mellitus. Cardiovascular Diabetology. 2020; 19: 183.","DOI":"10.1186\/s12933-020-01157-7"}],"container-title":["Reviews in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/24\/5\/10.31083\/j.rcm2405153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T18:45:02Z","timestamp":1732733102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/24\/5\/10.31083\/j.rcm2405153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,19]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"alternative-id":["S1530-6550(23)00906-7"],"URL":"https:\/\/doi.org\/10.31083\/j.rcm2405153","relation":{},"ISSN":["1530-6550","2153-8174"],"issn-type":[{"value":"1530-6550","type":"print"},{"value":"2153-8174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,19]]},"article-number":"153"}}